This is the authors' abstract. We don't add key points for this paper.
Objectives The seroprevalence of antibodies against Cytomegalovirus (CMV) is an established poor prognostic factor for patients receiving an allogeneic stem cell transplantation. However, the impact of CMV serology on outcome after autologous stem cell transplantation remains unknown.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Salwender et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: